Cognitive therapy for suicide prevention (CT-SP) in combination with treatment as usual (TAU) is more effective in reducing the severity and intensity of suicide ideation and suicidal behavior than only receiving treatment as usual.
ID
Bron
Verkorte titel
Aandoening
Suicide prevention
Cognitive behavioral therapy
Specialized mental health care
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary outcome measure is defined as the reduction of suicide ideation and suicidal behavior in terms of severity and intensity as measured by the Columbia-Suicide Severity Rating Scale (C-SSRS). Assessments of severity and intensity of suicidal ideation and behavior will be made at baseline, after 6 and 12 weeks after baseline, and 9 months after the baseline.
Achtergrond van het onderzoek
According to the World Health Organization (WHO), suicide is the 15th most frequent cause of death in the world and is responsible for approximately 800,000 deaths per year (WHO, 2014). It is of importance to further develop and implement interventions that focus on decreasing the number of deaths due to suicide. Improving mental health treatment and its availability for suicidal patients may be considered to be an important target when it comes to reducing the number of suicides, since studies indicate that 90-95% of the people that commit suicide were dealing with a mental health disorder (Cavanagh et al., 2003; Nock et al., 2008). Research has shown that cognitive behavioral therapy focused on suicide prevention (CT-sp) is capable of reducing suicidality in various populations (Meerwijk et al., 2016; Mewton, 2016l; Tarrier et al., 2008). The study ‘GGZ inteRvention In Prevention of suicidal behavior’ (GRIP) will investigate whether CT-SP is also effective for suicidal patients (ideators as well as attempters) within the Dutch outpatient mental health care via a randomized controlled trial.
Doel van het onderzoek
Cognitive therapy for suicide prevention (CT-SP) in combination with treatment as usual (TAU) is more effective in reducing the severity and intensity of suicide ideation and suicidal behavior than only receiving treatment as usual.
Onderzoeksopzet
There are 4 measurement moments: T0 (baseline), T1 (6 weeks after baseline), T2 (12 weeks after baseline), and T3 (9 months after baseline).
Onderzoeksproduct en/of interventie
12 sessions of CT-SP delivered face-to-face by a trained psychologist.
Publiek
J. (Jasper) Wiebenga
Oldenaller 1
Amsterdam 1081 HJ
The Netherlands
020 788 4634
j.wiebenga01@ggzingeest.nl
Wetenschappelijk
J. (Jasper) Wiebenga
Oldenaller 1
Amsterdam 1081 HJ
The Netherlands
020 788 4634
j.wiebenga01@ggzingeest.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Age 18 and above
- Patient newly referred to or in care in a participating sGGZ mental health care center
- Patient scores 2 or higher on the severity subscale of the C-SSRS in the past month
- Patient additionally scores 3 or higher on at least one of the first three items of the intensity subscale of the C-SSRS in the past month and/or made a suicide attempt in his/her lifetime as rated by the suicidal behavior subscale of the C-SSRS.
- Speaking the Dutch language
- Patient is inclined to participate in a randomization process
- Patient is inclined to give written informed consent
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Active (manic-)psychotic episode or cognitive impairment due to chronic (psychotic) disorganization, dementia, or mental retardation
- Insufficient mastery of the Dutch language
- Has previously had cognitive behavioral therapy for suicide prevention
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL6927 |
| NTR-old | NTR7123 |
| CCMO | NL65579.029.18 |
| OMON | NL-OMON48958 |